Gynaecological aspects of tamoxifen treatment in breast cancer patients.
Obwegeser
R
R
Department of Obstetrics and Gynaecology, Vienna University Hospital, Austria.
Auerbach
L
L
Kubista
E
E
D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D016889:Endometrial Neoplasms / Q000139:chemically induced; D004965:Estrogen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D005836:Genitalia, Female / Q000187:drug effects*; D006801:Humans; D016609:Neoplasms, Second Primary / Q000139:chemically induced; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D013629:Tamoxifen